Connect Biopharma Holdings Ltd - ADR

NASDAQ:CNTB  
17.96
+0.33 (+1.87%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Connect Biopharma Holdings Ltd - ADR Stock, NASDAQ:CNTB

Science & Technology Park, 3/F, East R&D Building, Taicang, Jiangsu 215400
China
Phone: +86.512.53577866
Number of Employees:

Description

Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.